EUVIMEDEUVIMED entdecken
Editorial

Propensity Score–Matched External Controls in Rare Disease Trials: A Promising Tool Requiring Rigorous Validation

Emily C Zabor iD

Journal of Clinical Oncology · 20.07.2026 · 44 (21) · 1962-1965

DOI: 10.1200/jco-26-00816 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.07.2026. Verfasst von Emily C Zabor. Beteiligte Einrichtung: Department of Quantitative Health Sciences, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH. Die Arbeit nennt 13 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Quantitative Health Sciences, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH.

ORCID-Profile: Emily C Zabor

Zitieren

APA

Zabor, E. C. (2026). Propensity Score–Matched External Controls in Rare Disease Trials: A Promising Tool Requiring Rigorous Validation. Journal of Clinical Oncology, 44(21), 1962-1965. https://doi.org/10.1200/jco-26-00816

Vancouver

Zabor EC. Propensity Score–Matched External Controls in Rare Disease Trials: A Promising Tool Requiring Rigorous Validation. Journal of Clinical Oncology. 2026;44(21):1962-1965. doi:10.1200/jco-26-00816

BibTeX
@article{Zabor2026,
  author = {Zabor, Emily C},
  title = {Propensity Score–Matched External Controls in Rare Disease Trials: A Promising Tool Requiring Rigorous Validation},
  journal = {Journal of Clinical Oncology},
  year = {2026},
  volume = {44},
  number = {21},
  pages = {1962--1965},
  doi = {10.1200/jco-26-00816}
}
Kostenlos starten →